Director, PV & Safety Technology Strategy

Alnylam Pharmaceuticals, Inc.

EE. UU.

Híbrido

USD 230.000 - 320.000

Jornada completa

Hace 2 días

Sé de los primeros/as/es en solicitar esta vacante

Una candidatura completa en un minuto

Currículum y carta de presentación personalizados, listos para enviar.

Supera los filtros ATS

Descripción de la vacante

Alnylam Pharmaceuticals, Inc. seeks a Director of Pharmacovigilance & Safety Technology to shape the technology strategy for Safety & Risk Management and to lead a team delivering scalable, compliant PV platforms across the product lifecycle.

The role partners with Safety, Quality, Data, Compliance, and enterprise Technology to enable inspection-ready, data-driven operations, leveraging AI-enabled workflows and modern safety systems. Hybrid role in Cambridge, MA with 2–3 days onsite.

Formación

Degree in IT, CS, Data Science, Life Sciences, Pharmacy, or related field in regulated life sciences.
12+ years in life sciences technology, pharmacovigilance, safety tech, or related regulated roles.
Deep PV processes knowledge; capable of leading design, governance, and delivery across PV systems.
Experience with PV technologies, data models, reporting, and analytics.
Familiarity with 21 CFR Part 11, data integrity, validation, audit readiness.

Responsabilidades

Serve as the functional technology leader for Safety & Risk Management and related PV functions.
Define and maintain the safety technology roadmap translating priorities into platform investments.
Lead platforms, workflows, case management, regulatory reporting, and analytics for PV.
Own the technology partnership model including governance, delivery, and value realization.
Establish accountability between Safety and Technology for reliable, compliant operations.
Guide teams and vendors to deliver scalable, secure, and user-centered PV solutions.